Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study
BRITISH JOURNAL OF HAEMATOLOGY（2022）
关键词
anti-C5 inhibitor, C5 polymorphism, COMPOSER, crovalimab, paroxysmal nocturnal haemoglobinuria
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要